Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro model

IntroductionOsteoarthritis (OA) is a chronic degenerative joint disease characterized by the progressive degradation of articular cartilage, resulting in pain and reduced mobility. Turmeric (Curcuma longa L.) has been widely recognized for its anti-inflammatory and antioxidant properties, but the mo...

Full description

Saved in:
Bibliographic Details
Main Authors: Federico Ghiselli, Roberta Majer, Andrea Piva, Ester Grilli
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1488254/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850167113166094336
author Federico Ghiselli
Roberta Majer
Andrea Piva
Ester Grilli
Ester Grilli
author_facet Federico Ghiselli
Roberta Majer
Andrea Piva
Ester Grilli
Ester Grilli
author_sort Federico Ghiselli
collection DOAJ
description IntroductionOsteoarthritis (OA) is a chronic degenerative joint disease characterized by the progressive degradation of articular cartilage, resulting in pain and reduced mobility. Turmeric (Curcuma longa L.) has been widely recognized for its anti-inflammatory and antioxidant properties, but the molecular mechanisms underlying its therapeutic effects remain inadequately explored. This study investigates the potential of turmeric oleoresin (TUR) to activate Cannabinoid Receptor 2 (CBR2) and its role in mediating anti-inflammatory and antioxidant effects in an in vitro OA model.Material and methodsMolecular docking and cAMP quantification assays were used to evaluate TUR’s agonistic activity on CBR2. Human chondrosarcoma cells (SW-1353) were treated with TUR under oxidative stress induced by menadione or inflammatory conditions simulated with IL-1β and TNF-α. The effects of TUR were assessed in the presence and absence of the CBR2 antagonist SR144528. Outcomes included changes in reactive oxygen species (ROS) production, inflammatory marker expression, oxidative defense markers and endocannabinoid system components and receptors.ResultsTUR was confirmed as a CBR2 agonist and significantly reduced ROS production, downregulated pro-inflammatory cytokines (IL-6, COX-2, metalloproteases), and suppressed signaling pathways such as NFKB1, ERK 1/2, and c-Myc. These effects were reversed upon CBR2 inhibition. TUR also enhanced HMOX-1 expression and modulated endocannabinoid-related enzymes, highlighting its impact on oxidative stress and the endocannabinoid system.DiscussionThese findings suggest that CBR2 activation is central to TUR’s anti-inflammatory and antioxidant effects. By modulating key pathways and endocannabinoid system components, TUR demonstrates potential as a novel therapeutic agent for OA management. Future studies could explore its clinical applications and further validate its molecular mechanisms in vivo.
format Article
id doaj-art-91d3e390ebbd4c19afcf0586010dc3e2
institution OA Journals
issn 1663-9812
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-91d3e390ebbd4c19afcf0586010dc3e22025-08-20T02:21:16ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122024-12-011510.3389/fphar.2024.14882541488254Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro modelFederico Ghiselli0Roberta Majer1Andrea Piva2Ester Grilli3Ester Grilli4Vetagro S.P.A., Reggio Emilia, ItalyVetagro S.P.A., Reggio Emilia, ItalyVetagro S.P.A., Reggio Emilia, ItalyDipartimento di Scienze Mediche Veterinarie, Università di Bologna, Bologna, ItalyVetagro Inc., Chicago, IL, United StatesIntroductionOsteoarthritis (OA) is a chronic degenerative joint disease characterized by the progressive degradation of articular cartilage, resulting in pain and reduced mobility. Turmeric (Curcuma longa L.) has been widely recognized for its anti-inflammatory and antioxidant properties, but the molecular mechanisms underlying its therapeutic effects remain inadequately explored. This study investigates the potential of turmeric oleoresin (TUR) to activate Cannabinoid Receptor 2 (CBR2) and its role in mediating anti-inflammatory and antioxidant effects in an in vitro OA model.Material and methodsMolecular docking and cAMP quantification assays were used to evaluate TUR’s agonistic activity on CBR2. Human chondrosarcoma cells (SW-1353) were treated with TUR under oxidative stress induced by menadione or inflammatory conditions simulated with IL-1β and TNF-α. The effects of TUR were assessed in the presence and absence of the CBR2 antagonist SR144528. Outcomes included changes in reactive oxygen species (ROS) production, inflammatory marker expression, oxidative defense markers and endocannabinoid system components and receptors.ResultsTUR was confirmed as a CBR2 agonist and significantly reduced ROS production, downregulated pro-inflammatory cytokines (IL-6, COX-2, metalloproteases), and suppressed signaling pathways such as NFKB1, ERK 1/2, and c-Myc. These effects were reversed upon CBR2 inhibition. TUR also enhanced HMOX-1 expression and modulated endocannabinoid-related enzymes, highlighting its impact on oxidative stress and the endocannabinoid system.DiscussionThese findings suggest that CBR2 activation is central to TUR’s anti-inflammatory and antioxidant effects. By modulating key pathways and endocannabinoid system components, TUR demonstrates potential as a novel therapeutic agent for OA management. Future studies could explore its clinical applications and further validate its molecular mechanisms in vivo.https://www.frontiersin.org/articles/10.3389/fphar.2024.1488254/fullosteoarthritisinflammationturmericanti-inflammatoryantioxidantendocannabinoid system
spellingShingle Federico Ghiselli
Roberta Majer
Andrea Piva
Ester Grilli
Ester Grilli
Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro model
Frontiers in Pharmacology
osteoarthritis
inflammation
turmeric
anti-inflammatory
antioxidant
endocannabinoid system
title Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro model
title_full Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro model
title_fullStr Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro model
title_full_unstemmed Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro model
title_short Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro model
title_sort activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro model
topic osteoarthritis
inflammation
turmeric
anti-inflammatory
antioxidant
endocannabinoid system
url https://www.frontiersin.org/articles/10.3389/fphar.2024.1488254/full
work_keys_str_mv AT federicoghiselli activationofcannabinoidreceptor2byturmericoleoresinreducesinflammationandoxidativestressinanosteoarthritisinvitromodel
AT robertamajer activationofcannabinoidreceptor2byturmericoleoresinreducesinflammationandoxidativestressinanosteoarthritisinvitromodel
AT andreapiva activationofcannabinoidreceptor2byturmericoleoresinreducesinflammationandoxidativestressinanosteoarthritisinvitromodel
AT estergrilli activationofcannabinoidreceptor2byturmericoleoresinreducesinflammationandoxidativestressinanosteoarthritisinvitromodel
AT estergrilli activationofcannabinoidreceptor2byturmericoleoresinreducesinflammationandoxidativestressinanosteoarthritisinvitromodel